<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Cystic fibrosis (CF) is a rare genetic condition affecting more than 90,000 people worldwide. Despite implementation of neonatal newborn screening programs in some countries and improvement in patient care over the last few years, CF-related lung disease remains the main cause of morbidity-mortality in these patients. The role of bacterial pathogens such as 
 <italic>Staphylococcus aureus</italic> (SA) and 
 <italic>Pseudomonas aeruginosa</italic> (PA) has been extensively studied for several decades whereas the respiratory viruses pathogenesis remained little explored. The availability of new diagnostic molecular tests to detect virus infections has recently boosted the interest in evaluating their impact during pathological conditions such as CF in children [
 <xref ref-type="bibr" rid="CR1">1</xref>–
 <xref ref-type="bibr" rid="CR9">9</xref>] and in adults [
 <xref ref-type="bibr" rid="CR10">10</xref>–
 <xref ref-type="bibr" rid="CR15">15</xref>].
</p>
